Enhancing surgical outcomes: accurate identification and removal of prostate cancer with B7-H3-targeted NIR-II molecular imaging
ConclusionThe findings revealed that B7-H3 was a compelling imaging target for PCa. The AbB7 −H3-800CW molecular imaging probe is capable of accurately identifying PCa lesions and guiding their removal. This approach can potentially reduce the rate of surgical margins under NIR-II fluorescence guidance.
Source: European Journal of Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Source Type: research
More News: Benign Prostatic Hyperplasia | Cancer | Cancer & Oncology | Nuclear Medicine | Prostate Cancer | Study